四环生物(000518) - 2015 Q3 - 季度财报

Financial Performance - Operating revenue for the current period was CNY 67,145,232.57, representing a year-on-year increase of 26.73%[7] - Net profit attributable to shareholders was a loss of CNY 8,721,814.15, a decrease of 249.90% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 3,146,803.15, an increase of 622.66% year-on-year[7] - Basic and diluted earnings per share were both CNY -0.0085, a decrease of 249.12% year-on-year[7] - Operating profit fell by 65.00% to ¥11,661,594.58, reflecting a decrease in main business income compared to the same period last year[15] Cash Flow and Assets - The net cash flow from operating activities was a negative CNY 164,141,020.64, a decrease of 1,993.59% compared to the same period last year[7] - Cash and cash equivalents decreased by 74.74% to ¥8,778,029.92 due to new prepayments from subsidiaries[15] - The company reported a 1993.59% increase in cash flow from operating activities, resulting in a net outflow of ¥164,141,020.64, driven by increased inventory and receivables[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 169,782[11] - The largest shareholder, Kunshan Venture Capital Co., Ltd., held 3.95% of the shares, totaling 40,645,169 shares[11] - No agreed repurchase transactions were conducted by the top ten ordinary shareholders during the reporting period[12] Inventory and Receivables - Accounts receivable increased by 32.41% to ¥111,669,823.69, attributed to increased receivables from Beijing Sihuan compared to the same period last year[15] - Inventory surged by 305.77% to ¥171,820,522.82, primarily due to new inventory from the wholly-owned subsidiary Chenwei Ecological Park[15] Financial Expenses and Income - Financial expenses increased by 6138.13% to ¥4,175,043.39, due to higher borrowing costs at Jiangsu Sihuan Biopharmaceutical[15] - The company recorded a 470.82% increase in non-operating income to ¥1,014,980.25, including a one-time payment of ¥1 million for technology transfer[15] Strategic Developments - The company established Jiangsu Chenwei Ecological Park Technology Co., Ltd. and initiated a non-public stock issuance to enhance its competitive edge in the agricultural sector[17] - The company faced challenges with the Xinjiang Aidi project, which is currently suspended due to low international oil prices and funding shortages[17] Borrowings - Short-term borrowings increased by ¥35,000,000.00, reflecting new loans taken by Jiangsu Sihuan Biopharmaceutical[16] Asset Growth - Total assets increased by 4.57% to CNY 855,442,572.59 compared to the end of the previous year[7] - The weighted average return on net assets was -1.28%, down from -0.68% at the beginning of the year[7]